Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia
- PMID: 38339940
- PMCID: PMC10977406
- DOI: 10.3233/JPD-230331
Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia
Abstract
Alterations of serotonin type 4 receptor levels are linked to mood disorders and cognitive deficits in several conditions. However, few studies have investigated 5-HT4R alterations in movement disorders. We wondered whether striatal 5-HT4R expression is altered in experimental parkinsonism. We used a brain bank tissue from a rat and a macaque model of Parkinson's disease (PD). We then investigated its in vivo PET imaging regulation in a cohort of macaques. Dopaminergic depletion increases striatal 5-HT4R in the two models, further augmented after dyskinesia-inducing L-Dopa. Pending confirmation in PD patients, the 5-HT4R might offer a therapeutic target for dampening PD's symptoms.
Keywords: L-Dopa; PET imaging; Parkinson’s disease; dyskinesia; experimental animal models; immunohistochemistry; movement disorders; parkinsonism; serotonin.
Conflict of interest statement
The authors have no conflict of interest to report.
Erwan Bezard is an Editorial Board Member of this journal but was not involved in the peer-review process of this article nor had access to any information regarding its peer-review.
Figures


References
-
- Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson’s disease: Features and pathophysiological mechanisms. Lancet Neurol 8, 1128–1139. - PubMed
-
- Pagano G, Niccolini F, Fusar-Poli P, Politis M (2017) Serotonin transporter in Parkinson’s disease: A meta-analysis of positron emission tomography studies. Ann Neurol 81, 171–180. - PubMed
-
- Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominentrole of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease. Brain 139(Pt 9), 2486–2502. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous